Researcher.Life Logo

Pharmacogenomics Journal : Impact Factor & More

eISSN: 1473-1150pISSN: 1470-269X

Key Metrics

CiteScore
6.5
H-Index
93
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacogenomics Journal

Pharmacogenomics Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacogenomics Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacogenomics Journal

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.
  • 29 Jun 2026
  • The pharmacogenomics journal
Finasteride, pharmacogenomics, and suicide risk: a public health concern.
  • 9 Jun 2026
  • The pharmacogenomics journal
Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia.
  • 6 Jun 2026
  • The pharmacogenomics journal
Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in China.
  • 25 May 2026
  • The pharmacogenomics journal
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
  • 24 Apr 2026
  • The pharmacogenomics journal
Cost-effectiveness of genotype-guided acenocoumarol therapy in atrial fibrillation: a pharmacogenomic simulation study in the chilean population.
  • 20 Apr 2026
  • The pharmacogenomics journal
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.
  • 29 Jun 2026
  • The pharmacogenomics journal
Finasteride, pharmacogenomics, and suicide risk: a public health concern.
  • 9 Jun 2026
  • The pharmacogenomics journal
Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia.
  • 6 Jun 2026
  • The pharmacogenomics journal
Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in China.
  • 25 May 2026
  • The pharmacogenomics journal
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
  • 24 Apr 2026
  • The pharmacogenomics journal
Cost-effectiveness of genotype-guided acenocoumarol therapy in atrial fibrillation: a pharmacogenomic simulation study in the chilean population.
  • 20 Apr 2026
  • The pharmacogenomics journal

FAQs on Pharmacogenomics Journal